SCHEMBL372687

SCHEMBL372687

CC(NN)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL372686 1.00
SCHEMBL18528958 1.00
Hydrochloric Acid SCHEMBL21801938 0.97
Hydrochloric Acid SCHEMBL11411903 0.97
Hydrochloric Acid SCHEMBL20304486 0.97
SCHEMBL8639205 0.77
SCHEMBL15123396 0.77
SCHEMBL23019171 0.75
SCHEMBL2718684 0.75
SCHEMBL29089183 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 288 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119092134-B Acute aortic dissection early risk prediction method and system based on blood examination 西南医科大学附属医院 2025-01-28 CN claimed
CN-115433999-B Method for growing all-inorganic lead-free perovskite single crystal 四川大学 2023-05-26 CN claimed
EP-3248003-B1 METHOD FOR DETERMINING THE DISTINCTIVE NUTRITIONAL REQUIREMENTS OF A PATIENT NESTLE SA (CH) 2023-04-19 EP claimed
CN-114748672-B Composite hemostatic sponge and preparation method and application thereof 北京化工大学 2023-03-31 CN claimed
US-11614442-B2 Method for determining the distinctive nutritional requirements of a patient SOCIETE DES PRODUITS NESTLE S.A. (CH) 2023-03-28 US claimed
CN-114748672-A Composite hemostatic sponge and preparation method and application thereof 北京化工大学 2022-07-15 CN claimed
US-20200378955-A1 METHOD FOR DETERMINING THE DISTINCTIVE NUTRITIONAL REQUIREMENTS OF A PATIENT SOCIETE DES PRODUITS NESTLE S.A. (CH) 2020-12-03 US claimed
US-10768169-B2 Method for determining the distinctive nutritional requirements of a patient SOCIETE DES PRODUITS NESTLE S.A. (CH) 2020-09-08 US claimed
EP-3612548-A1 METHODS FOR REMOVING BACTERIAL TOXINS FROM A BIOLOGICAL FLUID SETLANCE S.r.l. (IT) 2020-02-26 EP claimed
US-20200048307-A1 METHODS FOR REMOVING BACTERIAL TOXINS FROM A BIOLOGICAL FLUID SETLANCE S.R.L. (IT) 2020-02-13 US claimed
EP-1789436-A1 ANTIBACTERIAL PEPTIDES AND ANALOGUES THEREOF Universita' Degli Studi di Siena (IT) 2007-05-30 EP claimed
EP-1737883-A2 SYNTHETIC PEPTIDES CONTAINING THE MOTIF \"YWWLXP\" AS ANTHRAX TOXIN ANTIDOTES Universita' Degli Studi di Siena (IT) 2007-01-03 EP claimed
EP-1397380-B1 MULTIPLE ANTIGENIC PEPTIDE DISPLAYING MULTIPLE COPIES OF AN EPITOPE OF A PLAQUE-FORMING POLYPEPTIDE AND METHODS OF USING SAME UNIV RAMOT (IL) 2006-12-27 EP claimed
WO-2006006195-A1 ANTIBACTERIAL PEPTIDES AND ANALOGUES THEREOF UNIVERSITÀ DEGLI STUDI DI SIENA (IT) 2006-01-19 WO claimed
WO-2005095444-A2 SYNTHETIC PEPTIDES CONTAINING THE MOTIF ‘YWWLXP’ AS ANTHRAX TOXIN ANTIDOTES UNIVERSITÀ DEGLI STUDI DE SIENA (IT) 2005-10-13 WO claimed
US-20050080260-A1 Preparation of prodrugs for selective drug delivery LUMINIDE 2005-04-14 US claimed
US-20050053575-A1 Antigenic product displaying multiple copies of an epitope of a deposit-forming polypeptide involved in plaque-forming diseases and methods of using same RAMOT AT TEL AVIV UNIVERSITY LTD (IL) 2005-03-10 US claimed
EP-1397380-A2 MULTIPLE ANTIGENIC PEPTIDE DISPLAYING MULTIPLE COPIES OF AN EPITOPE OF A PLAQUE-FORMING POLYPEPTIDE AND METHODS OF USING SAME Ramot at Tel Aviv University Ltd. (IL) 2004-03-17 EP claimed
CN-1469867-A Novel phenylalanine derivatives ֮����ʽ���� 2004-01-21 CN claimed
WO-2003000719-A2 MULTIPLE ANTIGENIC PEPTIDE DISPLAYING MULTIPLE COPIES OF AN EPITOPE OF PLAQUE-FORMING POLYPEPTIDE AND METHODS OF USING SAME RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2003-01-03 WO claimed